넥살린 테크놀로지NXL 주가

Discover the top movers in Friday's pre-market session.

Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury

U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy

Nexalin Technology Secures Key Neurostimulation Legislative Provision In Appropriations Bill Passed By U.S. House Of Representatives

The U.S. House of Representatives-approved report language, which was secured through the Company's Nexalin America division, includes the following report language under the "Non-Invasive Neurostimulation for Traumatic

Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial

Acquisition gives Nexalin control of AI-integrated remote patient-monitoring, clinical data-capture and virtual-care infrastructure already deployed at UCSDHOUSTON, TX, May 19, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. ( (Nasdaq: NXL) (“Nexalin” or the “Company”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the closing of its acquisition of PONM, Inc. (“PONM”) from GreenLight Ventures, LLC (“GreenLight”). PONM is the digital he

Nexalin Technology Acquires Digital Health Platform PONM From GreenLight Ventures; Financial Terms Not Disclosed

Through the transaction, Nexalin has secured ownership of PONM and an exclusive license to the proprietary software features developed for the HALO™ program, including AI-integrated remote patient monitoring,

[8-K] 중대 사건 — 8-K

[10-Q] 분기 실적 — 10-Q

[8-K] 중대 사건 — 8-K

[10-K] 연 실적 — 10-K

[8-K] 중대 사건 — 8-K